Roles of cytokines and T cells in the pathogenesis of myasthenia gravis - Uzawa - 2021 - Clinical & Experimental Immunology - Wiley Online Library
Frontiers | Myasthenia Gravis: Autoantibody Specificities and Their Role in MG Management
Frontiers | Immunoregulatory Cells in Myasthenia Gravis
Mortality rates and causes of death in Swedish Myasthenia Gravis patients
Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets - The Lancet Neurology
Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK | PLOS ONE
Incidence of Thymoma in Myasthenia Gravis: A Systematic Review
Incidence, mortality, and economic burden of myasthenia gravis in China: A nationwide population-based study
Mortality rates and causes of death in Swedish Myasthenia Gravis patients - ScienceDirect
MyastheniaGravis.cz - Instructions for anaesthetists
ICD-10 Codes for Reporting Myasthenia Gravis (MG)
Comorbid nervous system manifestations and disorders with myasthenia gravis: Evidences and possible mechanisms
Myasthenia Gravis – from weakness shall come strength
Medical IDs for Myasthenia Gravis | MedicAlert Foundation
Risk factors for pregnancy-related clinical outcome in myasthenia gravis: a systemic review and meta-analysis | Orphanet Journal of Rare Diseases | Full Text
Berberine attenuates experimental autoimmune myasthenia gravis via rebalancing the T cell subsets - ScienceDirect
Myasthenia Gravis
Myasthenia Gravis – from weakness shall come strength
Frontiers | Immunopathology of Autoimmune Myasthenia Gravis: Implications for Improved Testing Algorithms and Treatment Strategies
